Like a woman’s libido, the name of the new drug approved to treat female sexual dysfunction is hard to understand—let alone pronounce. Yes, as if women struggling with hypoactive sexual desire ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi (R) has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of ...

Addyi is the first FDA-approved treatment for women's sexual dysfunction. Debra Dillo shares how her marriage has changed since she started the medication We had a wonderful family life growing up. I ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved ...

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

Ten years since the landmark approval of the first and only FDA-authorized pill clinically proven to treat low libido in women, Sprout Pharmaceuticals CEO Cindy Eckert reflects on advancements and ...

Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the most trusted and influential honors a brand ...